Abstract:OBJECTIVE:To investigate the relationship between clinical features of patients with A/H5N1 infection and their prognosis in mainland China. METHODS:This study included 28 human cases with A/H5N1 infection in mainland China from October 2005 to May 2008. Data were collected and reviewed from hospital medical records and publishied papers. A database was built by EPIDATA 3.02 and statistical analyses were performed with SPSS 13.0. RESULTS:The median age of the 28 cases was 29 years (range 6-62), and 15 were females. Ten patients survived, and 18 died. The typically clinical manifestations of human influenza A/H5N1 infection included fever and lower respiratory infection. The numbers of peripheral white blood cells, lymphocytes and platelets in the survival and non-survival groups were (4.01 +/- 1.86) x 10(9)/L vs (5.1 +/- 2.9) x 10(9)/L, (1.09 +/- 0.49) x 10(9)/L vs (0.98 +/- 0.44) x 10(9)/L, and (116 +/- 39) x 10(9)/L vs (101 +/- 40) x 10(9)/L, respectively; the differences were not statistically significant between the 2 groups (P>0.05). There was also no statistically significant difference in the increased serum enzymes, such as aspartate aminotransferase [(173 +/- 246) U/L vs (272 +/- 263) U/L], lactate dehydrogenase [(1016 +/- 568) U/L vs (1512 +/- 1052) U/L], creatine kinase [(1099 +/- 1590) U/L vs (2534 +/- 4281) U/L] and MB isoenzyme of creatine kinase [(28 +/- 30) U/L vs (125 +/- 197) U/L] (P>0.05) between the survival and the non-survival groups. However, there was a statistically significant difference in the number of patients with an initial LDH level more than 8 fold of the normal value between the survival and the non-survival groups (none vs 6, P<0.05). All of the 28 cases developed bilateral multiple infiltrates and consolidation in chest radiographs. Acute respiratory distress syndrome occurred in 22 cases, 17 of them died. All the 9 patients with acute kidney injury died. Ten patients received antiviral treatment with oseltamivir, and 6 of them survived. There was a statistical difference in the time of initiating oseltamivir treatment between the survival and the non-survival cases [(6.5 +/- 3.0) d vs (11.8 +/- 3.3) d, Z = 3.70, P<0.05]. Broad spectrum antibiotics and corticosteroids were administered in all of the 28 cases. There was no statistical difference between the survival and the non-survival groups regarding to the corticosteroid treatment (P>0.05). CONCLUSIONS:Initial LDH level reaching more than 8 fold of the normal value suggests a poor prognosis for human H5N1 infection. Patients complicated with either ARDS or acute kidney injury had a higher risk of death. Early administration of effective antiviral agents might improve the prognosis and decrease case fatality.

Evaluation of Plasma Exchange and Continuous Veno‐Venous Hemofiltration for the Treatment of Severe Avian Influenza <scp>A</scp> (<scp>H7N9</scp>): A Cohort Study

Evaluation of Plasma Exchange and Continuous Veno-Venous Hemofiltration for the Treatment of Severe Avian Influenza A (H7N9): a Cohort Study.

Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.

Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma.

The Serum Profile of Hypercytokinemia Factors Identified in H7n9-Infected Patients Can Predict Fatal Outcomes

Immune derangement occurs in patients with H7N9 avian influenza

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.

A New Perspective on C-Reactive Protein in H7n9 Infections

Severe Infection with Avian Influenza A Virus is Associated with Delayed Immune Recovery in Survivors

[The clinical characteristics and prognosis of 20 patients with H7N9 avian influenza].

Analysis of the Clinical Characteristics and Treatment of Two Patients with Avian Influenza Virus (H7N9).

Effects of Continuous Veno-Venous Hemofiltration on Respiratory Function of Critical Patients with Influenza A/H1N1

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.

Prognosis and efficacy of integrative treatment for novel H7N9 avian influenza virus infection in human

[Relationship Between Clinical Features and Prognosis of Highly Pathogenic Avian Influenza A/H5N1 Infection in Humans in Mainland China].

Recovered and Dead Outcome Patients Caused by Influenza A (H7N9) Virus Infection Show Different Pro-Inflammatory Cytokine Dynamics During Disease Progress and Its Application in Real-Time Prognosis

Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor.

Novel Pathogenic Characteristics of Highly Pathogenic Avian Influenza Virus H7N9: Viraemia and Extrapulmonary Infection

Angiotensin II Plasma Levels Are Linked to Disease Severity and Predict Fatal Outcomes in H7N9-infected Patients.